Insuline Medical Ltd

TA:INSL Israel Other
Market Cap
$7.24K
ILA2.70 Million ILA
Market Cap Rank
#45494 Global
#449 in Israel
Share Price
ILA270.00
Change (1 day)
-11.48%
52-Week Range
ILA121.00 - ILA357.00
All Time High
ILA730501.20
About

Yaad Sihan Projects Management and Entrepreneurship Ltd. is headquartered in Jerusalem, Israel.

Insuline Medical Ltd (INSL) - Total Liabilities

Latest total liabilities as of December 2017: ILA1.64 Million ILA

Based on the latest financial reports, Insuline Medical Ltd (INSL) has total liabilities worth ILA1.64 Million ILA as of December 2017.

Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.

Insuline Medical Ltd - Total Liabilities Trend (2013–2017)

This chart illustrates how Insuline Medical Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.

Insuline Medical Ltd Competitors by Total Liabilities

The table below lists competitors of Insuline Medical Ltd ranked by their total liabilities.

Company Country Total Liabilities
XINHUA PHARMA -H- (XIN.SG)
STU:XIN
Germany €3.73 Billion
Sharing Services Global Corp
PINK:SHRG
USA $10.47 Million
AIR CHINA -H-
BE:AD2
Germany €306.57 Billion
Forward Science Corp.
TWO:7530
Taiwan NT$293.18 Million
Sipup Corporation
PINK:SPUP
USA $335.22K
Colefax Group
LSE:CFX
UK GBX42.80 Million

Liability Composition Analysis (2013–2017)

This chart breaks down Insuline Medical Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.98 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity -26.08 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 1.04 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Insuline Medical Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Insuline Medical Ltd (2013–2017)

The table below shows the annual total liabilities of Insuline Medical Ltd from 2013 to 2017.

Year Total Liabilities Change
2017-12-31 ILA1.64 Million -82.03%
2016-12-31 ILA9.14 Million +9.77%
2015-12-31 ILA8.33 Million -4.82%
2014-12-31 ILA8.75 Million -29.50%
2013-12-31 ILA12.41 Million --